MPGN 2 Bibliography
Bennett WM, Fassett RB, Walker RG, Fairley KF, d'Apice AJF, Kincaid
Smith P. Mesangiocapillary glomerulonephritis type II (Dense deposit
disease): clinical features of progressive disease. American Journal of
Kidney Diseases, XIII(6): 469-476, 1989.
Brai M, Misiano G, Maringhini S, Cutaja I, Hauptmann G. Combined
homozygous factor H and heterozygous C2 deficiency in an Italian family.
J Clin Immunol 8:50-56, 1988.
Cameron JS: Glomerulonephritis in renal transplants. Transplantation
34:237-245, 1982.
Davis AE III, Schneeberger EE, Grupe WE, et al. Membranoproliferative
glomerulonephritis (MPGN type 1) and dense deposit disease (DDD) in
children. Clin Nephrol 9:184-193, 1978.
Eddy A, Sibley R, Mauer SM, Kim Y. Renal allograft failure due to
recurrent dense intramembranous deposit disease. Clinical Nephrology
21:(6) 305-313, 1984.
Habib R, Antignac C, Hinglais N, Gagnadoux MF, Broyer M. Glomerular
lesions in the transplanted kidney in children. American Journal of Kidney
Diseases, X(3) 198-207, 1987.
Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M. Hereditary
porcine membranoproliferative glomerulonephritis type II is caused by
factor H deficiency. J Clin Invest 95:1054- 1061, 1995.
Hulton S-A, Risdon RA, Dillon MJ. Mesangiocapillary glomerulonephritis
associated with meningococcal meningitis, C3 nephritic factor and
persistently low complement C3 and C5. Pediatr Nephrol 6: 239-243,
1992.
Lamb V, Tisher CC, McCoy RC, Robinson RR. Membranoproliferative
glomerulonephritis with dense intramembranous alterations. Laboratory
Investigation 36(6): 607-617, 1977.
Levy M, Halbwachs-Mecarelli L, Gubler MC, Kohout G, Bensenouci P,
Niaudet G, Hauptmann G, Lesavre P. H deficiency in two brothers with
atypical dense intramembranous deposit disease. Kidney Int 30: 949-956,
1986.
Lopez-Larrea C, Dieguez MA, Enguix A, Dominquez O, Marin B, Gomez E.
A familial deficiency of complement factor H. Biochem Soc Trans 15: 648649, 1987.
McEnery PT, McAdams AJ, West CD. Membranoproliferative
glomerulonephritis: Improved survival with alternate day prednisone
therapy. Clin Nephrol 13:117-124, 1980.
Moritz MJ, Burke JF, Jarrell BE, Carabasi RA. The incidence of
membranoproliferative glomerulonephritis in renal allografts.
Transplantation Proceedings, XIX(1): 2206-2207, 1987.
Muda AO, Barsotti P, Marinozzi V. Ultrastructural histochemical
investigations of "dense deposit disease". Pathogenetic approach to a
special type of mesangiocapillary glomerulonephritis. Virchows Archiv A
Pathol Anat 413: 529-537, 1988.
Schwertz R, de Jong R, Gretz N, Kirschfink M, Anders D, Scharer D,
Arbeitsgemeinschaft Padiatrische Nephrologie. Outcome of idiopathic
membranoproliferative glomerulonephritis in children. Acta Paediatr
85:308-312, 1996.
Thompson RA, Winterborn MH. Hypocomplementemia due to a genetic
deficiency of beta 1H globulin. Clin Exp Immunol 46: 110-119, 1981.
West CD, McAdams AJ. Paramesangial glomerular deposits in
membranoproliferative glomerulonephritis type II correlate with
hypocomplementemia. Am J Kid Dis 25: 853-861, 1995.